Speaker illustration

Professor Lars Lund

Karolinska University Hospital, Stockholm (Sweden)

Member of:

European Society of Cardiology
Heart Failure Association

Lars Lund is Professor of Cardiology at Karolinska Institutet and Karolinska University Hospital in Stockholm. His research focuses on heart failure: implementation of existing therapy in HFrEF and development of novel therapy in HFpEF.

Registry-based research in heart failure: when is it useful?

Event: Heart Failure 2023

Topic: Big Data Analysis

Session type: Symposium

Thumbnail

HF clinical trials of 2022

Event: Heart Failure 2023

Topic: Heart Failure Association (HFA)

Session type: Case-Based Session

Thumbnail

Chronic heart failure - HFpEF - HFrEF - HFmREF

Event: ESC Congress 2022

Topic: Pathophysiology and Mechanisms

Session type: Moderated ePosters

Thumbnail

HFpEF and HFmrEF: what’s new in treatment?

Event: ESC Congress 2022

Topic: Pathophysiology and Mechanisms

Session type: Abstract Sessions

Thumbnail

Registries and Trial updates II

Event: Heart Failure 2022

Topic: Chronic Heart Failure

Session type: Late-Breaking Science

Thumbnail

Heart failure patient profile and outcome 2

Event: Heart Failure 2022

Topic: Chronic Heart Failure

Session type: Moderated Posters

Thumbnail

Scientific wrap-up

Event: Heart Failure 2022

Topic: Chronic Heart Failure

Session type: Special Session

Thumbnail

Preventing sudden death in heart failure

Event: ESC Congress 2021 - The Digital Experience

Topic: Chronic Heart Failure

Session type: Symposium

Thumbnail

Late Breaking Science in Heart Failure

Event: ESC Congress 2021 - The Digital Experience

Topic: Chronic Heart Failure

Session type: Late-Breaking Science

Thumbnail

Chronic Heart Failure - Epidemiology, Prognosis, Outcome

Event: Heart Failure 2021

Topic: Epidemiology, Prognosis, Outcome

Session type: Abstract Sessions

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb